Vijay Kumar
Stock Analyst at Evercore ISI Group
(3.48)
# 928
Out of 5,113 analysts
281
Total ratings
52.94%
Success rate
3.46%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: In-Line | $580 → $550 | $528.81 | +4.01% | 15 | Jan 23, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $144 → $138 | $108.77 | +26.87% | 18 | Jan 23, 2026 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $168 → $223 | $205.11 | +8.72% | 9 | Jan 13, 2026 | |
| HOLX Hologic | Downgrades: In-Line | $79 → $78 | $75.19 | +3.74% | 17 | Jan 5, 2026 | |
| EXAS Exact Sciences | Downgrades: In-Line | $105 | $102.51 | +2.43% | 8 | Jan 5, 2026 | |
| BLCO Bausch + Lomb | Downgrades: In-Line | $18 | $16.87 | +6.70% | 12 | Jan 5, 2026 | |
| AVTR Avantor | Downgrades: In-Line | $14 → $12 | $11.79 | +1.78% | 13 | Jan 5, 2026 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Outperform | $94 → $120 | $87.32 | +37.43% | 15 | Jan 5, 2026 | |
| IRTC iRhythm Holdings | Upgrades: Outperform | $194 → $210 | $161.62 | +29.93% | 3 | Jan 5, 2026 | |
| AZTA Azenta | Upgrades: Outperform | $34 → $50 | $39.86 | +25.44% | 9 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $155 → $160 | $135.65 | +17.95% | 8 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $410 → $405 | $356.98 | +13.45% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $132 → $142 | $153.00 | -7.19% | 9 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $92 | $84.27 | +9.17% | 15 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $92 | $80.27 | +14.61% | 5 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $42 | $42.46 | -1.08% | 6 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $525 → $590 | $626.62 | -5.84% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $108 → $106 | $114.70 | -7.59% | 3 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $285 | $359.00 | -20.61% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,275 → $1,400 | $1,425.67 | -1.80% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $226 → $245 | $236.71 | +3.50% | 4 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $110 | $93.55 | +17.58% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $31 | $19.65 | +57.76% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $49 → $54 | $55.83 | -3.28% | 7 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $40 | $25.79 | +55.10% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 → $106 | $100.67 | +5.29% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $22.72 | +102.46% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $2.71 | +10.70% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $13.26 | +126.24% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $390.90 | -9.18% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $82.03 | +95.05% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $203.42 | +42.56% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.19 | +488.24% | 1 | May 31, 2022 |
Intuitive Surgical
Jan 23, 2026
Maintains: In-Line
Price Target: $580 → $550
Current: $528.81
Upside: +4.01%
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $144 → $138
Current: $108.77
Upside: +26.87%
J.B. Hunt Transport Services
Jan 13, 2026
Maintains: Outperform
Price Target: $168 → $223
Current: $205.11
Upside: +8.72%
Hologic
Jan 5, 2026
Downgrades: In-Line
Price Target: $79 → $78
Current: $75.19
Upside: +3.74%
Exact Sciences
Jan 5, 2026
Downgrades: In-Line
Price Target: $105
Current: $102.51
Upside: +2.43%
Bausch + Lomb
Jan 5, 2026
Downgrades: In-Line
Price Target: $18
Current: $16.87
Upside: +6.70%
Avantor
Jan 5, 2026
Downgrades: In-Line
Price Target: $14 → $12
Current: $11.79
Upside: +1.78%
Zimmer Biomet Holdings
Jan 5, 2026
Upgrades: Outperform
Price Target: $94 → $120
Current: $87.32
Upside: +37.43%
iRhythm Holdings
Jan 5, 2026
Upgrades: Outperform
Price Target: $194 → $210
Current: $161.62
Upside: +29.93%
Azenta
Jan 5, 2026
Upgrades: Outperform
Price Target: $34 → $50
Current: $39.86
Upside: +25.44%
Jan 5, 2026
Upgrades: Outperform
Price Target: $155 → $160
Current: $135.65
Upside: +17.95%
Oct 31, 2025
Maintains: Outperform
Price Target: $410 → $405
Current: $356.98
Upside: +13.45%
Oct 31, 2025
Maintains: Outperform
Price Target: $132 → $142
Current: $153.00
Upside: -7.19%
Oct 31, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $84.27
Upside: +9.17%
Oct 30, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $80.27
Upside: +14.61%
Oct 7, 2025
Maintains: Outperform
Price Target: $46 → $42
Current: $42.46
Upside: -1.08%
Oct 7, 2025
Maintains: Outperform
Price Target: $525 → $590
Current: $626.62
Upside: -5.84%
Oct 7, 2025
Maintains: Outperform
Price Target: $108 → $106
Current: $114.70
Upside: -7.59%
Oct 7, 2025
Maintains: Outperform
Price Target: $300 → $285
Current: $359.00
Upside: -20.61%
Oct 7, 2025
Maintains: Outperform
Price Target: $1,275 → $1,400
Current: $1,425.67
Upside: -1.80%
Oct 7, 2025
Maintains: Outperform
Price Target: $226 → $245
Current: $236.71
Upside: +3.50%
Oct 7, 2025
Maintains: Outperform
Price Target: $115 → $110
Current: $93.55
Upside: +17.58%
Oct 7, 2025
Maintains: Outperform
Price Target: $33 → $31
Current: $19.65
Upside: +57.76%
Sep 30, 2025
Maintains: In-Line
Price Target: $49 → $54
Current: $55.83
Upside: -3.28%
Aug 13, 2025
Maintains: Outperform
Price Target: $33 → $40
Current: $25.79
Upside: +55.10%
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $100.67
Upside: +5.29%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $22.72
Upside: +102.46%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $2.71
Upside: +10.70%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $13.26
Upside: +126.24%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $390.90
Upside: -9.18%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $82.03
Upside: +95.05%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $203.42
Upside: +42.56%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $1.19
Upside: +488.24%